Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

PhaseBio Pharmaceuticals Inc (PHAS)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16
   10-K10-K10-K10-K10-KS-1/A
Net income  -131.1-98.6-39.2-23.8-10.2-9.2
Depreciation and amortization  1.80.50.20.10.10.1
Stock-based compensation  2.32.21.40.30.10.2
Change in working capital   [+]56.522.6-1.42.30.1-0.5
Other operating activities  23.113.3-0.54.11.7-0.2
Cash from operations  -47.4-60.0-39.6-17.1-8.3-9.7
   
Capital expenditures  -2.7-1.3-1.0-0.1-0.2-0.1
Purchases of intangible assets   -0.1    
Sales of short-term investments, net   [+]     9.4
Other cash from investing       0.0
Cash from investing  -2.7-1.4-1.0-0.1-0.29.2
   
Issuance of common stock, net  60.42.946.343.0  
Option exercises  0.40.10.20.10.0 
Other cash from financing  3.812.67.521.918.20.0
Cash from financing  63.815.553.564.818.20.0
   
Free cash flow  -50.1-61.3-40.6-17.2-8.5-9.8
        Per share (diluted)  ($1.14)($2.11)($1.48)($3.24)($11.40)($13.17)
   
Cash paid for interest  0.51.00.60.30.0 

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy